양극성 조증 입원 환자에서 과체중, 비만과 연관 인자：예비 연구
Factors Associated with Overweight and Obesity in Inpatients with Bipolar Mania： A Preliminary Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective：Being overweight or obesity impairs quality of life and often causes treatment noncompliance in patients with bipolar disorder. This preliminary study evaluated the prevalence of overweight and obesity in inpatients with bipolar mania. Methods：Inpatients with bipolar mania, who were treated with adequate medications at least 4 weeks were included in a retrospective study. The body weight of each patient was measured and the body mass index (BMI) was calculated. Results：Of the 80 patients, 16.4% (N=13) were overweight, and 35.0% (N=28) were obese at discharge. Female patients had higher prevalence rates of overweight and obesity. Being overweight or obesity was associated with the number of previous episodes of depression and combination treatment with atypical antipsychotics and mood stabilizers. Conclusions：Being overweight or obesity is highly prevalent in patients with bipolar mania. Clinicians should pay more attention to weight gain and obesity when prescribing combination therapies. More research is required to identify the impact of specific risk factors for overweight and obesity in patients with bipolar mania.
Abstract
Objective：Being overweight or obesity impairs quality of life and often causes treatment noncompliance in patients with bipolar disorder. This preliminary study evaluated the prevalence of overweight and obesity in inpatients with bipolar mania. Methods：Inpatients with bipolar mania, who were treated with adequate medications at least 4 weeks were included in a retrospective study. The body weight of each patient was measured and the body mass index (BMI) was calculated. Results：Of the 80 patients, 16.4% (N=13) were overweight, and 35.0% (N=28) were obese at discharge. Female patients had higher prevalence rates of overweight and obesity. Being overweight or obesity was associated with the number of previous episodes of depression and combination treatment with atypical antipsychotics and mood stabilizers. Conclusions：Being overweight or obesity is highly prevalent in patients with bipolar mania. Clinicians should pay more attention to weight gain and obesity when prescribing combination therapies. More research is required to identify the impact of specific risk factors for overweight and obesity in patients with bipolar mania.
참고문헌 (35)
- Haslam DW, "Obesity", Lancet, 366, pp.1197~1209 (2005)
- James PT, "The Worldwide Obesity", Epidemic Obes Res, 9, pp.228~233 (2001)
- Behn A, "The obesity epidemic and its cardiovascular consequences", Curr Opin Cardiol, 21, pp.353~360 (2006)
- Rosenbaum M, "Medical progress: obesity", N Engl J Med, 337, pp.396~407 (1997)
- Kurzthaler I, "The clinical implications of weight gain in schizophrenia", J Clin Psychiatry, 62(7), pp.32~37 (2001)
- Keck PE, "Bipolar disorder, obesity, and pharmacotherapy- associated weight gain", J Clin Psychiatry, 64, pp.1426~1435 (2003)
- Malhotra S, "Associations between metabolic syndrome and psychiatric disorder", Prim Psychiatry, 10, pp.37~44 (2003)
- Fagiolini A, "Prevalence of obesity and weight change during treatment in patients with bipolar I disorder", J Clin Psychiatry, 63, pp.528~534 (2002)
- Elmslie JL, "Determinants of overweight and obesity in patients with bipolar disorder", J Clin Psychiatry, 62, pp.486~491 (2001)
- Ramacciotti CE, "Relationship between bipolar illness and bingeeating disorders", Psychiatry Res, 135, pp.165~170 (2005)
- Kruger S, "Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder", Int J Eat Disord, 19, pp.45~52 (1996)
- Vornik LA, "Management of comorbid bipolar disorder and substance abuse", J Clin Psychiatry, 67(7), pp.24~30 (2006)
- Grant BF, "Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions", Arch Gen Psychiatry, 61, pp.1107~1115 (2004)
- Taylor V, "Associations between bipolar disorder and metabolic syndrome: a review", J Clin Psychiatry, 67, pp.1034~1041 (2006)
- Fava M, "Weight gain and antidepressants", J Clin Psychiatry, 61(11), pp.37~41 (2000)
- Wirshing DA, "Novel antipsychotics: comparison of weight gain liabilities", J Clin Psychiatry, 60, pp.358~363 (1999)
- Nemeroff CB, "Safety of available agents used to treat bipolar disorder: focus on weight gain", J Clin Psychiatry, 64, pp.532~539 (2003)
- American Psychiatry Association, "Diagnostic and Statistical Manual of Mental Disorder 4th ed" (1994), American Psychiatric Press
- Kanazawa M, "Criteria and classification of obesity in Japan and Asia-Oceania", World Rev Nutr Diet, 94, pp.1~12 (2005)
- Kim DM, "Prevalence of obesity in Korea", Obes Rev, 6, pp.117~121 (2005)
- Elmslie JL, "Prevalence of over weight and obesity in bipolar patients", J Clin Psychiatry, 61, pp.179~184 (2000)
- McElroy SL, "Correlates of overweight and obesity in 644 patients with bipolar disorder", J Clin Psychiatry, 63, pp.207~213 (2002)
- Kim B, "Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients", J Affect Disord, 105, pp.45~52 (2008)
- Shi H, "Sex differences in the regulation of body weight", Physiol Behav, 97, pp.199~204 (2009)
- Phillips GB, "Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome?", Studies in women. Metabolism, 57, pp.838~844 (2008)
- Stedman T, "The distribution of adipose tissue in female patients receiving psychotropic drugs", Br J Psychiatry, 162, pp.249~250 (1993)
- Silverstone T, "Prevalence of obesity in patients receiving depot antipsychotics", Br J Psychiatry, 153, pp.214~217 (1988)
- Allison DB, "The distribution of body mass index among individuals with and without schizophrenia", J Clin Psychiatry, 60, pp.215~220 (1999)
- Vestergaard P, "Prospective studies in a lithium cohort, 3: tremor, weight gain, diarrhea, psychological complaints", Acta Psychiatr Scand, 78, pp.434~441 (1988)
- Bowden CL, "A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group", Arch Gen Psychiatry, 57, pp.481~489 (2000)
- "Consensus development conference on antipsychotic drugs and obesity and diabetes", Diabetes Care, 27, pp.596~601 (2004)
- Marken PA, "Emerging treatments for bipolar disorder: safety and adverse effect profiles", Ann Pharmacother, 40, pp.276~285 (2006)
- Reynolds GP, "Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism", Lancet, 359, pp.2086~2087 (2002)
- Tohen M, "Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial", Am J Psychiatry, 162, pp.1281~1290 (2005)
- Tohen M, "Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study", Am J Psychiatry, 160, pp.1263~1271 (2003)